Personalized Nutrition

Translating Nutrigenetic/Nutrigenomic Research into Dietary Guidelines

Editor(s): Simopoulos A.P. (Washington, D.C.) 
Milner J.A. (Rockville, Md.) 
Table of Contents
Vol. 101, No. , 2010
Section title: Paper
Simopoulos AP, Milner JA (eds): Personalized Nutrition. World Rev Nutr Diet. Basel, Karger, 2010, vol 101, pp 34–45

Xenobiotic Metabolizing Genes, Meat-Related Exposures, and Risk of Advanced Colorectal Adenoma

Ferrucci L.M. · Cross A.J. · Gunter M.J. · Ahn J. · Mayne S.T. · Ma X. · Chanock S.J. · Yeager M. · Graubard B.I. · Berndt S.I. · Huang W.-Y. · Hayes R.B. · Sinha R.
aDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Md., bYale School of Public Health, New Haven, Conn., cDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, and dDivision of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, N.Y, USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

First-Page Preview
Abstract of Paper

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Sinha R, Norat T: Meat cooking and cancer risk. IARC Sci Publ 2002;156:181-186
  2. Cross AJ, Sinha R: Meat-related mutagens/carcinogens in the etiology of colorectal cancer. Environ Mol Mutagen 2004;44:44-55
  3. World Cancer Research Fund/American Institute for Cancer Research: Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington DC, AICR, 2007;
  4. Sinha R, Cross A, Curtin J, et al: Development of a food frequency questionnaire module and databases for compounds in cooked and processed meats. Mol Nutr Food Res 2005;49:648-655
  5. Ito N, Hasegawa R, Sano M, et al: A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP). Carcinogenesis 1991;12:1503-1506
  6. Ochiai M, Imai H, Sugimura T, Nagao M, Nakagama H: Induction of intestinal tumors and lymphomas in C57BL/6N mice by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn J Cancer Res 2002;93:478-483
  7. Ohgaki H, Takayama S, Sugimura T: Carcinogenicities of heterocyclic amines in cooked food. Mut Res 1991;259:399-410
  8. Bogovski P, Bogovski S: Animal Species in which N-nitroso compounds induce cancer. Int J Cancer 1981;27:471-474
  9. Mirvish SS: Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 1995;93:17-48
  10. Mirvish SS, Haorah J, Zhou L, et al: Total N-nitroso compounds and their precursors in hot dogs and in the gastrointestinal tract and feces of rats and mice: possible etiologic agents for colon cancer. J Nutr 2002;132:(suppl 11)3526S-3529S
  11. Cross AJ, Pollock JR, Bingham SA: Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat. Cancer Res 2003;63:2358-2360
  12. Hughes R, Cross AJ, Pollock JR, Bingham S: Dosedependent effect of dietary meat on endogenous colonic N-nitrosation. Carcinogenesis 2001;22:199-202
  13. Xue W, Warshawsky D: Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol Appl Pharmacol 2005;206:73-93
  14. Shimada T: Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcino-genic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 2006;21:257-276
  15. Nebert DW, Dalton TP: The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 2006;6:947-960
  16. Glatt H, Pabel U, Meinl W, et al: Bioactivation of the heterocyclic aromatic amine 2-amino-3-methyl-9H-pyrido [2,3-b]indole (MeAalphaC) in recombinant test systems expressing human xenobiotic- metabolizing enzymes. Carcinogenesis 2004;25:801-807
  17. Muckel E, Frandsen H, Glatt HR: Heterologous expression of human N-acetyltransferases 1 and 2 and sulfotransferase 1A1 in Salmonella typhimurium for mutagenicity testing of heterocyclic amines. Food Chem Toxicol 2002;40:1063-1068
  18. Turesky RJ: Interspecies metabolism of heterocyclic aromatic amines and the uncertainties in extrapolation of animal toxicity data for human risk assessment. Mol Nutr Food Res 2005;49:101-117
  19. Tranah GJ, Giovannucci E, Ma J, et al: Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses’ Health Study and the Health Professionals Follow-up Study. Carcinogenesis 2004;25:1211-1218
  20. Tiemersma EW, Voskuil DW, Bunschoten A, et al: Risk of colorectal adenomas in relation to meat consumption, meat preparation, and genetic susceptibility in a Dutch population. Cancer Causes Control 2004;15:225-236
  21. Shin A, Shrubsole MJ, Rice JM, et al: Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk. Cancer Epidemiol Biomarkers Prev 2008;17:320-329
  22. Ishibe N, Sinha R, Hein DW, et al: Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. Pharmacogenetics 2002;12:145-150
  23. Roberts-Thomson IC, Ryan P, Khoo KK, et al: Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet 1996;347:1372-1374
  24. Tiemersma EW, Kloosterman J, Bunschoten A, Kok FJ, Kampman E: Role of EPHX genotype in the associations of smoking and diet with colorectal adenomas. IARC Sci Publ 2002;156:491-493
  25. Ulrich CM, Bigler J, Whitton JA, et al: Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev 2001;10:875-882
  26. Cortessis V, Siegmund K, Chen Q, et al: A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas. Cancer Res 2001;61:2381-2385
  27. Goode EL, Potter JD, Bamlet WR, Rider DN, Bigler J: Inherited variation in carcinogen-metabolizing enzymes and risk of colorectal polyps. Carcino-genesis 2007;28:328-341
  28. Ward MH, Cross AJ, Divan H, et al: Processed meat intake, CYP2A6 activity and risk of colorectal adenoma. Carcinogenesis 2007;28:1210-1216
  29. Saebo M, Skjelbred CF, Brekke Li K, et al: CYP1A2 164 A→C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas. Anticancer Res 2008;28:2289-2295
  30. Skjelbred CF, Saebo M, Hjartaker A, et al: Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas. BMC Cancer 2007;7:228
  31. Winawer SJ, Zauber AG, Ho MN, et al: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup: N Engl J Med 1993;329:1977-1981
  32. Anderson WF, Guyton KZ, Hiatt RA, et al: Colorectal cancer screening for persons at average risk. J Natl Cancer Inst 2002;94:1126-1133
  33. Stryker SJ, Wolff BG, Culp CE, et al: Natural history of untreated colonic polyps. Gastroenterology 1987;93:1009-1013
  34. Sinha R, Peters U, Cross AJ, et al: Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res 2005;65:8034-8041
  35. Prorok PC, Andriole GL, Bresalier RS, et al: Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21:(suppl 6)273S-309S
  36. Gohagan JK, Prorok PC, Hayes RB, Kramer BS: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 2000;21:(suppl 6)251S-272S
  37. Moore LE, Huang WY, Chatterjee N, et al: GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2005;14:1823-1827
  38. Chapman JM, Cooper JD, Todd JA, Clayton DG: Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Hum Hered 2003;56:18-31
  39. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I: Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125:279-284
  40. Huang WY, Chatterjee N, Chanock S, et al: Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2005;14:152-157
  41. Moslehi R, Chatterjee N, Church TR, et al: Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma. Pharmacogenomics 2006;7:819-829
  42. Hou L, Chatterjee N, Huang WY, et al: CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis 2005;26:1122-1128
  43. Mukherjee B, Chatterjee N: Exploiting gene-environment independence for analysis of case-control studies: an empirical bayes-type shrinkage estimator to trade-off between bias and efficiency. Biometrics 2008;64:685-694
  44. Shimada T, Fujii-Kuriyama Y: Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci 2004;95:1-6
  45. Cotterchio M, Boucher BA, Manno M, et al: Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2008;17:3098-3107
  46. Kury S, Buecher B, Robiou-du-Pont S, et al: Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumption. Cancer Epidemiol Biomarkers Prev 2007;16:1460-1467
  47. Han JF, He XY, Herrington JS, et al: Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human CYP1B1 genetic variants. Drug Metab Dispos 2008;36:745-752
  48. Rihs HP, Pesch B, Kappler M, et al: Occupational exposure to polycyclic aromatic hydrocarbons in German industries: association between exogenous exposure and urinary metabolites and its modulation by enzyme polymorphisms. Toxicol Lett 2005;157:241-255
  49. Lamba JK, Lin YS, Schuetz EG, Thummel KE: Genetic contribution to variable human CYP3Amediated metabolism. Adv Drug Deliv Rev 2002;54:1271-1294
  50. Canaparo R, Finnstrom N, Serpe L, et al: Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum. Clin Exp Pharmacol Physiol 2007;34:1138-1144
  51. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270:414-423
  52. Wojnowski L, Kamdem LK: Clinical implications of CYP3A polymorphisms. Expert Opin Drug Metab Toxicol 2006;2:171-182
  53. Murtaugh MA, Sweeney C, Ma KN, Caan BJ, Slattery ML: The CYP1A1 genotype may alter the association of meat consumption patterns and preparation with the risk of colorectal cancer in men and women. J Nutr 2005;135:179-186
  54. Kobayashi M, Otani T, Iwasaki M, et al: Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: a hospital-based case-control study in Japan. Scand J Gastroenterol 2009;1-8
  55. Turner F, Smith G, Sachse C, et al: Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer. Int J Cancer 2004;112:259-264
  56. Nowell S, Sweeney C, Hammons G, Kadlubar FF, Lang NP: CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:377-383
  57. Le Marchand L, Donlon T, Seifried A, Wilkens LR: Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1019-1024
  58. Morita M, Le Marchand L, Kono S, et al: Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Epidemiol Biomarkers Prev 2009;18:235-241
  59. Robien K, Curtin K, Ulrich CM, et al: Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:1350-1352
  60. Lilla C, Risch A, Verla-Tebit E, et al: SULT1A1 genotype and susceptibility to colorectal cancer. Int J Cancer 2007;120:201-206
  61. Tiemersma EW, Kampman E: Bueno de Mesquita HB, et al: Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study. Cancer Causes Control 2002;13:383-393
  62. Moreno V, Glatt H, Guino E, et al: Polymorphisms in sulfotransferases SULT1A1 and SULT1A2 are not related to colorectal cancer. Int J Cancer 2005;113:683-686
  63. Lilla C, Verla-Tebit E, Risch A, et al: Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol Biomarkers Prev 2006;15:99-107
  64. Nothlings U, Yamamoto JF, Wilkens LR, et al: Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2009;18:2098-2106
  65. Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL: Polymorphisms of cytochrome P450 1A2 and N-acetyltransferase genes, meat consumption, and risk of colorectal cancer. Dis Colon Rectum 2009;52:104-111

Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00